N6AMT1
Basic information
Region (hg38): 21:28872191-28885371
Previous symbols: [ "C21orf127", "HEMK2" ]
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the N6AMT1 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 0 | |||||
missense | 19 | 21 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 0 | |||||
Total | 0 | 0 | 19 | 2 | 0 |
Variants in N6AMT1
This is a list of pathogenic ClinVar variants found in the N6AMT1 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
21-28876407-A-G | not specified | Uncertain significance (Apr 12, 2023) | ||
21-28878201-T-C | not specified | Uncertain significance (Jan 06, 2023) | ||
21-28878251-G-A | Likely benign (Jan 01, 2023) | |||
21-28878273-C-T | not specified | Uncertain significance (Apr 09, 2024) | ||
21-28878321-C-T | not specified | Uncertain significance (Jan 30, 2024) | ||
21-28879883-G-C | not specified | Uncertain significance (Mar 21, 2024) | ||
21-28879884-T-G | not specified | Uncertain significance (Oct 18, 2021) | ||
21-28879887-C-G | not specified | Uncertain significance (Aug 10, 2021) | ||
21-28879895-G-C | not specified | Uncertain significance (Dec 28, 2022) | ||
21-28879908-C-T | not specified | Uncertain significance (Apr 12, 2022) | ||
21-28879938-G-A | not specified | Uncertain significance (Sep 16, 2021) | ||
21-28882234-G-A | not specified | Uncertain significance (Jul 27, 2024) | ||
21-28882986-T-C | not specified | Uncertain significance (Aug 01, 2024) | ||
21-28883046-A-C | not specified | Likely benign (Oct 12, 2022) | ||
21-28885219-G-C | not specified | Uncertain significance (Sep 13, 2023) | ||
21-28885233-G-T | not specified | Uncertain significance (Oct 07, 2022) | ||
21-28885257-A-T | not specified | Uncertain significance (Apr 17, 2023) | ||
21-28885269-G-A | not specified | Uncertain significance (Aug 02, 2021) | ||
21-28885272-G-A | not specified | Uncertain significance (Jun 16, 2023) | ||
21-28885293-G-C | not specified | Uncertain significance (Feb 05, 2024) | ||
21-28885294-C-T | not specified | Uncertain significance (Aug 20, 2024) | ||
21-28885302-C-T | not specified | Uncertain significance (Aug 28, 2024) | ||
21-28885305-A-T | not specified | Uncertain significance (Sep 03, 2024) | ||
21-28885309-G-T | not specified | Uncertain significance (Dec 26, 2023) | ||
21-28885320-G-A | not specified | Uncertain significance (Jul 17, 2024) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
N6AMT1 | protein_coding | protein_coding | ENST00000303775 | 6 | 13181 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.00000682 | 0.293 | 124720 | 0 | 1007 | 125727 | 0.00401 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | -0.230 | 123 | 116 | 1.06 | 0.00000549 | 1349 |
Missense in Polyphen | 28 | 36.289 | 0.77158 | 422 | ||
Synonymous | 0.0938 | 43 | 43.8 | 0.982 | 0.00000219 | 440 |
Loss of Function | 0.0962 | 8 | 8.30 | 0.964 | 3.47e-7 | 112 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.00705 | 0.00661 |
Ashkenazi Jewish | 0.000931 | 0.000893 |
East Asian | 0.00447 | 0.00370 |
Finnish | 0.0167 | 0.0162 |
European (Non-Finnish) | 0.00368 | 0.00343 |
Middle Eastern | 0.00447 | 0.00370 |
South Asian | 0.000445 | 0.000425 |
Other | 0.00287 | 0.00261 |
dbNSFP
Source:
- Function
- FUNCTION: Methyltransferase that can methylate both proteins and DNA, and to a lower extent, arsenic (PubMed:18539146, PubMed:21193388, PubMed:30017583). Catalytic subunit of a heterodimer with TRMT112, which catalyzes N5-methylation of Glu residue of proteins with a Gly-Gln-Xaa-Xaa-Xaa-Arg motif (PubMed:18539146) (By similarity). Methylates ETF1 on 'Gln-185'; ETF1 needs to be complexed to ERF3 in its GTP-bound form to be efficiently methylated (PubMed:18539146, PubMed:20606008). Also acts as a N(6)-adenine-specific DNA methyltransferase by mediating methylation of DNA on the 6th position of adenine (N(6)- methyladenosine) (PubMed:30017583). N(6)-methyladenosine (m6A) DNA is significantly enriched in exonic regions and is associated with gene transcriptional activation (PubMed:30017583). May also play a role in the modulation of arsenic-induced toxicity by mediating the conversion of monomethylarsonous acid (3+) into the less toxic dimethylarsonic acid (PubMed:21193388, PubMed:25997655). It however only plays a limited role in arsenic metabolism compared with AS3MT (PubMed:25997655). {ECO:0000250|UniProtKB:Q6SKR2, ECO:0000269|PubMed:18539146, ECO:0000269|PubMed:20606008, ECO:0000269|PubMed:21193388, ECO:0000269|PubMed:25997655, ECO:0000269|PubMed:30017583}.;
- Pathway
- Methylation;Phase II - Conjugation of compounds;Eukaryotic Translation Termination;Translation;Metabolism of proteins;Biological oxidations;Metabolism
(Consensus)
Recessive Scores
- pRec
- 0.0959
Intolerance Scores
- loftool
- rvis_EVS
- 0.73
- rvis_percentile_EVS
- 86.08
Haploinsufficiency Scores
- pHI
- 0.490
- hipred
- N
- hipred_score
- 0.292
- ghis
- 0.420
Essentials
- essential_gene_CRISPR
- E
- essential_gene_CRISPR2
- E
- essential_gene_gene_trap
- E
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.464
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- N6amt1
- Phenotype
- growth/size/body region phenotype; embryo phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span);
Gene ontology
- Biological process
- toxin metabolic process;peptidyl-glutamine methylation;arsonoacetate metabolic process;positive regulation of cell growth;methylation;DNA methylation on adenine
- Cellular component
- nucleus;cytosol;protein-containing complex;eRF1 methyltransferase complex
- Molecular function
- nucleic acid binding;protein binding;protein methyltransferase activity;S-adenosylmethionine-dependent methyltransferase activity;site-specific DNA-methyltransferase (adenine-specific) activity;methylarsonite methyltransferase activity;protein-glutamine N-methyltransferase activity